Latest Galectin Stories
NEW YORK, Aug.
WILMINGTON, Del., Aug. 6, 2014 /PRNewswire/ -- Rigrodsky & Long, P.A.: -- Do you, or did you, own shares of Galectin Therapeutics Inc.
WAYNE, Pa., July 30, 2014 /PRNewswire/ -- Ryan & Maniskas, LLP has commenced an investigation into potential
NEW YORK, July 30, 2014 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Galectin
La Jolla acquires GCS-100 for treatment of cancer and chronic organ failure, appoints new CEO and director Scottsdale, AZ (PRWEB) January 22, 2012
WELLESLEY HILLS, Mass., June 15 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn") announced today that in vitro studies have demonstrated that GCS-100 binds to and blocks the effects of galectin-3.
- An armed gangster.